Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea
· Delayed Price · Currency is KRW 4,100.00
-10.00 (-0.24%)
Mar 19, 2025, 9:00 AM KST
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 318.57 billion as of April 1, 2025. Its market cap has increased by 16.64% in one year.
Market Cap
318.57B
Enterprise Value
392.08B
Revenue
3.87B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,100.00
Market Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 318.57B, a decrease of -48.05%. That is a compound annual growth rate of -14.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 316.25B | -19.74% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 396.83T |
| SK hynix | 137.33T |
| LG Energy Solution | 83.30T |
| Samsung Biologics | 74.66T |
| Hyundai Motor Company | 44.69T |
| Celltrion | 38.03T |
| Kia Corporation | 37.52T |
| KB Financial Group | 29.19T |